A placebo-controlled trial of valproate in tardive dyskinesia. 1985

H A Nasrallah, and F J Dunner, and M McCalley-Whitters

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004409 Dyskinesia, Drug-Induced Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199) Dyskinesia, Medication-Induced,Medication-Induced Dyskinesia,Drug-Induced Dyskinesia,Drug-Induced Dyskinesias,Dyskinesia, Drug Induced,Dyskinesia, Medication Induced,Dyskinesias, Drug-Induced,Dyskinesias, Medication-Induced,Medication Induced Dyskinesia,Medication-Induced Dyskinesias
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014635 Valproic Acid A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. Dipropyl Acetate,Divalproex,Sodium Valproate,2-Propylpentanoic Acid,Calcium Valproate,Convulsofin,Depakene,Depakine,Depakote,Divalproex Sodium,Ergenyl,Magnesium Valproate,Propylisopropylacetic Acid,Semisodium Valproate,Valproate,Valproate Calcium,Valproate Sodium,Valproic Acid, Sodium Salt (2:1),Vupral,2 Propylpentanoic Acid

Related Publications

H A Nasrallah, and F J Dunner, and M McCalley-Whitters
January 1986, Indian journal of psychiatry,
H A Nasrallah, and F J Dunner, and M McCalley-Whitters
May 2006, Schizophrenia research,
H A Nasrallah, and F J Dunner, and M McCalley-Whitters
November 1979, The Journal of clinical psychiatry,
H A Nasrallah, and F J Dunner, and M McCalley-Whitters
May 1993, Biological psychiatry,
H A Nasrallah, and F J Dunner, and M McCalley-Whitters
January 1980, International pharmacopsychiatry,
H A Nasrallah, and F J Dunner, and M McCalley-Whitters
March 1984, The Medical journal of Australia,
H A Nasrallah, and F J Dunner, and M McCalley-Whitters
July 1978, The British journal of psychiatry : the journal of mental science,
H A Nasrallah, and F J Dunner, and M McCalley-Whitters
February 1979, The British journal of psychiatry : the journal of mental science,
H A Nasrallah, and F J Dunner, and M McCalley-Whitters
November 1979, Psychopharmacology,
H A Nasrallah, and F J Dunner, and M McCalley-Whitters
October 1983, Ceskoslovenska psychiatrie,
Copied contents to your clipboard!